Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04959981 Completed - Clinical trials for Advanced Non-squamous Non-small-cell Lung Cancer

A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC

HERKULES-2
Start date: September 2, 2021
Phase: Phase 1
Study type: Interventional

- To evaluate the safety and tolerability of escalating doses of ERAS-007 or ERAS-601 in combination with other cancer therapies in study participants with advanced non-small cell lung cancer (NSCLC). - To determine the Maximum Tolerated Dose (MTD) and/or Recommended Dose (RD) of ERAS-007 or ERAS-601 administered in combination with other cancer therapies. - To evaluate the antitumor activity of ERAS-007 or ERAS-601 in combination with other cancer therapies. - To evaluate the PK profiles of ERAS-007 or ERAS-601 and other cancer therapies when administered in combination.

NCT ID: NCT04959565 Completed - Clinical trials for Relative Energy Deficiency in Sport

Evaluation of a Practice-oriented Recovery Program for Female Endurance Athletes With Relative Energy Deficiency

Start date: October 8, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to develop, implement and evaluate the effects of a 16 week practice orientated sports nutrition education and counselling program aiming to improve energy availability and to investigate the effects on physiological and psychological health, sports nutrition knowledge, and athletic performance in well-trained female endurance athletes with risk of RED-S. The FUEL (in Norwegian: Forstå Utholdenhetsidretts Ernæring - et Læringsprogram; in English: Food and nUtrition for Endurance athletes - a Learning program) recovery program consists of virtual lectures with central themes within sports nutrition in addition to individual consultations.

NCT ID: NCT04959357 Completed - Clinical trials for Coronary Microvascular Dysfunction

The Evaluation of Left Ventricular Systolic Function in Different Types of Ischemic Heart Disease

Start date: March 15, 2018
Phase:
Study type: Observational

The study was designed to evaluate the left ventricular longitudinal strain and strain rate assessed by 2D-STI in patients with coronary microvascular dysfunction (CMD) or obstructive coronary artery disease (CAD) , to investigate the effect of different types of ischemic heart disease on the LV systolic function, and to explore the value of LS on the diagnosis of coronary microvascular dysfunction.

NCT ID: NCT04959110 Completed - Pharmacokinetic Clinical Trials

Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT

Citrate PK
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Citrate has been proposed as anticoagulation of choice in continuous renal replacement therapy (CRRT). However, little is known about the pharmacokinetics (PKs) and metabolism of citrate in liver failure patients who require CRRT with regional citrate anticoagulation (RCA).

NCT ID: NCT04958915 Completed - Clinical trials for Anterior Cruciate Ligament Injuries

Application of FMRI in Diagnosis of Anterior Cruciate Ligament Injury

Start date: March 1, 2018
Phase:
Study type: Observational

1. To compare the knee joint MRI 30 ° The flexion position was similar to that of conventional knee joint coil (about 17 °) The advantages and disadvantages in the description and diagnosis of anterior cruciate ligament injury;,2. To compare the knee joint MRI 30 ° The flexion position was similar to that of conventional knee joint coil (about 17 °) Advantages and disadvantages in description and diagnosis of patellofemoral instability

NCT ID: NCT04958603 Completed - Clinical trials for Lateral Patellar Compression Syndrome

The Clinical Effect of Different Lateral Retinaculum Relaxation Methods in the Treatment of LPCS

Start date: April 1, 2020
Phase:
Study type: Observational

To observe the comparison of the clinical effects of two different ways of loosening the lateral support band under arthroscopy to treat lateral patella excessive compression syndrome.

NCT ID: NCT04958369 Completed - Pacemaker Clinical Trials

Ultrasound-guided Axillary Versus Conventional Cephalic Venous Access for Implantation of Cardiac Devices

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The implantation of cardiac electronic devices is a common procedure in the Electrophysiology Laboratory. The most commonly used venous access sites are the cephalic, the axillary and the subclavian vein. Studies comparing these options have been conducted in the past. Axillary venous access can be achieved either through axillary vein angiography or by ultrasound guidance. Nevertheless, appropriate training is required for the ultrasound-guided axillary puncture technique-as well as for the cephalic vein cutdown technique. Data from randomized trials regarding direct comparison of the two methods in terms of efficacy and safety are very limited. The purpose of the study is the comparison of the efficacy and safety of the ultrasound-guided axillary venous access technique versus the cephalic venous access using the cut-down technique in patients requiring intravenous cardiac device (single-chamber/dual-chamber pacemaker/defibrillator) implantation.

NCT ID: NCT04957810 Completed - Clinical trials for Anterior Cruciate Ligament Injury

Evaluation of the Effect of Using WeChat Applet to Intervene in the Home Functional Exercise of Patients After Anterior Cruciate Ligament Reconstruction Based on the Health Belief Model

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Based on the home rehabilitation exercise of patients undergoing ACL reconstruction, the existing WeChat applet of sports medicine of the Third Hospital of Beijing Medical University is optimized to be used as a health education tool to guide patients undergoing home rehabilitation exercise after ACL reconstruction.

NCT ID: NCT04957589 Completed - Clinical trials for Diabetes Mellitus Type 2 in Obese

VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men

VLCDeXDM
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Sarcopenia is defined as the incremental age-related loss of skeletal muscle in humans which generally begins from forty years old. It is associated with an overall reduction in quality of life and increased morbidity and mortality. Patients with type two diabetes mellitus (T2DM) are particularly at risk of developing sarcopenia, partly due to the condition and also due to the common incidence after or during middle age. A promising recently-investigated and effective conservative approach to T2DM is through very low calorie diets (VLCD). Some studies have shown that the diabetic status of some patients can be reversed through VLCD. However, VLCD will theoretically result in an acceleration of sarcopenia. This presents as a limiting factor for the implementation of VLCD in this at-risk patient group. Skeletal muscle tissue is encouraged to grow in size or be maintained through two means - an increase in circulating protein breakdown products, or through resistance exercise (RE). Additionally, RE has been shown to increase the body's sensitivity to insulin, the main hormone which controls circulating glucose levels and is frequently impaired in T2DM, as well as temporarily decreasing glucose levels. The precise mechanism by which these happen is not fully understood yet. In this study, the effect of a VLCD is used, alongside one form of exercise (high intensity interval training, HIT), in overweight, middle-aged male patients with T2DM. 10 patients are to be recruited into each group (control/VLCD-only and VLCD with HIT) at our centre. Patient weight, markers of muscle protein synthesis, glucose levels and changes to blood vessels will be investigated before, during and after across a six week timeframe. Investigations will include muscle and fat biopsies, blood samples, ultrasound scans, strength testing and deuterium oxide (D2O) isotope ingestion for later non-invasive body fluid sample mass spectrometric analysis.

NCT ID: NCT04957472 Completed - Clinical trials for Respiratory Insufficiency in Children

Multicenter Study of the Safety and Performance of Fabian-PRICO for Saturation Targeting Routine Use in the NICU

Start date: January 14, 2022
Phase:
Study type: Observational

This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product. The purpose of the study is to demonstrate, in a routine clinical environment across a number of centers, that the fabian-PRICO can adequately maintain oxygen saturation, with minimal staff intervention.